PharmaVentures is a leading advisory firm in specialising in deals and alliances. The company largely focuses on M&A and Licensing mandates. With over 24 years of experience, PharmaVentures is trusted as a sell-side or buy-side advisor by a wide range of life sciences companies that include both large blue-chip pharmaceutical companies as well as mid-sized pharmaceutical companies, biotech/medtech companies, other life science players and private equity firms. In March 2016, 3Legs Resources appointed PharmaVentures as an adviser on the acquisition of SalvaRx, a company working in immuno-oncology. In February 2016, PharmaVentures acted as adviser to Transgene on the sale of its biopharmaceutical manufacturing unit in Strasbourg, France, to the US company Advanced Bioscience Laboratories (ABL), Inc.